Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | market report | table of contents
Iran Pharmaceuticals and Healthcare Report Q3 2008 (Business Monitor International)
- Market: Healthcare and Medical
- Report Title: Iran Pharmaceuticals and Healthcare Report Q3 2008
- View Report Summary: View Report Summary
- Report Type: Market Report
- Country: Iran
- Number of Pages: 69
Executive Summary .....5
SWOT Analysis ... 6
Table: Iran Pharmaceuticals And Healthcare Industry SWOT. 6
Iran Political SWOT .......... 7
Iran Economic SWOT ........ 8
Iran Business Environment SWOT 9
Business Environment Ranking ...........10
Iran – Business Environment Ranking.............. 10
Table: Pharmaceutical Business Environment Ratings........... 10
Limits Of Potential Returns ........ 10
Risks To Realisation Of Returns . 11
Market Summary ........12
Regulatory Regime ........13
Registration Of Imports ... 14
Generic Registration ........ 14
Intellectual Property (IP) Regime .... 15
Intellectual Property Disputes .... 15
Counterfeit Medicines ...... 16
Pricing And Reimbursement ....... 17
Industry Developments .......18
Health Status .. 18
HIV/AIDS Situation ......... 18
Iran HIV/AIDS Prevalence ......... 19
Healthcare Sector ............ 19
Primary Care .. 21
Secondary Care ............... 21
Retail Pharmacies ............ 21
Health Insurance ............. 22
Regional Developments ... 22
International Collaboration........ 23
Pharmaceutical Industry .. 23
Traditional Herbal Remedies...... 24
Recent Company Activity . 25
Research And Development ........ 26
International Co-operation......... 27
Industry Forecast Scenario .....29
Overall Market Forecast . 29
Table: Drug Expenditure Forecasts . 30
Key Growth Factors – Industry .. 31
Table: Health Expenditure Forecasts ............... 32
Key Growth Factors – Macroeconomic ............ 33
Table: Iran – Economic Activity . 36
Prescription Market Forecast..... 37
Table: Prescription Drug Market Forecast (US$bn unless otherwise stated) ...... 38
OTC Market Forecast ...... 39
Table: OTC Market Data Forecasts (US$bn unless otherwise stated) ...... 40
Generics And Patented Market Forecast .......... 41
Table: Generics And Patented Market Forecasts .. 42
Medical Device Market Forecast 43
Iran Medical Device Market Forecast .............. 45
Import/Export Market Forecast .. 46
Table: Pharmaceutical Trade Indicators (US$mn) 47
Other Healthcare Data Forecasts .... 48
Table: Other Health Indicators... 48
Key Risks To BMI’s Forecast Scenario............. 49
Competitive Landscape ......50
Company Profiles .....51
Multinationals ... 51
Novartis ..... 51
Merck & Co .... 51
Pfizer ......... 51
GlaxoSmithKline .............. 51
Sanofi-Aventis . 52
Indigenous Companies ....... 53
Darou Pakhsh . 53
Caspian Tamin Pharmaceutical Company*...... 55
Pharmieco . 57
Pars Darou 58
Zahravi ...... 60
Amin .......... 61
Sina Darou Pharmaceutical Company ............. 62
Exir Pharmaceuticals ...... 64
BMI Forecast Modelling ......65
How We Generate Our Pharmaceutical Industry Forecasts ..... 65
Pharmaceutical Business Environment Ratings Methodology .. 65
Ratings Overview ............. 66
Table: Pharmaceutical Business Environment Indicators ...... 67
Weighting ... 68
Table: Weighting Of Components .... 68
Sources ........ 68
SWOT Analysis ... 6
Table: Iran Pharmaceuticals And Healthcare Industry SWOT. 6
Iran Political SWOT .......... 7
Iran Economic SWOT ........ 8
Iran Business Environment SWOT 9
Business Environment Ranking ...........10
Iran – Business Environment Ranking.............. 10
Table: Pharmaceutical Business Environment Ratings........... 10
Limits Of Potential Returns ........ 10
Risks To Realisation Of Returns . 11
Market Summary ........12
Regulatory Regime ........13
Registration Of Imports ... 14
Generic Registration ........ 14
Intellectual Property (IP) Regime .... 15
Intellectual Property Disputes .... 15
Counterfeit Medicines ...... 16
Pricing And Reimbursement ....... 17
Industry Developments .......18
Health Status .. 18
HIV/AIDS Situation ......... 18
Iran HIV/AIDS Prevalence ......... 19
Healthcare Sector ............ 19
Primary Care .. 21
Secondary Care ............... 21
Retail Pharmacies ............ 21
Health Insurance ............. 22
Regional Developments ... 22
International Collaboration........ 23
Pharmaceutical Industry .. 23
Traditional Herbal Remedies...... 24
Recent Company Activity . 25
Research And Development ........ 26
International Co-operation......... 27
Industry Forecast Scenario .....29
Overall Market Forecast . 29
Table: Drug Expenditure Forecasts . 30
Key Growth Factors – Industry .. 31
Table: Health Expenditure Forecasts ............... 32
Key Growth Factors – Macroeconomic ............ 33
Table: Iran – Economic Activity . 36
Prescription Market Forecast..... 37
Table: Prescription Drug Market Forecast (US$bn unless otherwise stated) ...... 38
OTC Market Forecast ...... 39
Table: OTC Market Data Forecasts (US$bn unless otherwise stated) ...... 40
Generics And Patented Market Forecast .......... 41
Table: Generics And Patented Market Forecasts .. 42
Medical Device Market Forecast 43
Iran Medical Device Market Forecast .............. 45
Import/Export Market Forecast .. 46
Table: Pharmaceutical Trade Indicators (US$mn) 47
Other Healthcare Data Forecasts .... 48
Table: Other Health Indicators... 48
Key Risks To BMI’s Forecast Scenario............. 49
Competitive Landscape ......50
Company Profiles .....51
Multinationals ... 51
Novartis ..... 51
Merck & Co .... 51
Pfizer ......... 51
GlaxoSmithKline .............. 51
Sanofi-Aventis . 52
Indigenous Companies ....... 53
Darou Pakhsh . 53
Caspian Tamin Pharmaceutical Company*...... 55
Pharmieco . 57
Pars Darou 58
Zahravi ...... 60
Amin .......... 61
Sina Darou Pharmaceutical Company ............. 62
Exir Pharmaceuticals ...... 64
BMI Forecast Modelling ......65
How We Generate Our Pharmaceutical Industry Forecasts ..... 65
Pharmaceutical Business Environment Ratings Methodology .. 65
Ratings Overview ............. 66
Table: Pharmaceutical Business Environment Indicators ...... 67
Weighting ... 68
Table: Weighting Of Components .... 68
Sources ........ 68
Purchase Information There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
